2024-11-18 10:48:54
3-V Biosciences Commences Dosing in Phase 2 Clinical Study of the FASN Inhibitor TVB-2640 in Patients with NASH
Corporate/ 2023-07-23
3-V Biosciences Commences Dosing in Phas...

SAN MATEO,Calif. and HANGZHOU and SHAOXING,China,May 1,2019-- 3-V Biosciences,Inc. (3-V Biosciences) and Ascletis Pharma Inc. (Ascletis,1672...

CStone and Numab announce exclusive regional licensing agreement for ND021, a multi-functional drug candidate and potential next-generation immunotherapy
Corporate/ 2023-07-23
CStone and Numab announce exclusive regi...

SUZHOU,China and ZURICH,May 2,2019-- CStone Pharmaceuticals ("CStone"; HKEX: 2616) and Numab Therapeutics AG ("Numab") t...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release